Clinical characteristics and outcomes of Australian and Indian ST-segment elevation myocardial infarction (STEMI)

M L Savage1, K Hay2, H Sundar3

  • 1Cardiology Department, The Prince Charles Hospital, Brisbane, QLD, Australia; School of Clinical Medicine, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.

Indian Heart Journal
|August 24, 2024
PubMed

Insights

Indian patients with ST-elevation myocardial infarction (STEMI) presented younger and with more comorbidities, yet achieved faster in-hospital reperfusion times. Despite longer pre-hospital delays and lower post-procedure blood flow, 30-day and 1-year mortality rates were similar to Australian patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • ST-elevation myocardial infarction (STEMI) incidence and mortality are higher in Indian populations.
  • Limited comparative data exists on contemporary primary percutaneous coronary intervention (pPCI) for STEMI between developed and developing nations.

Purpose of the Study:

  • To compare demographics, treatment strategies, and clinical outcomes of STEMI patients treated with pPCI in India and Australia.
  • To identify differences in reperfusion times and mortality between the two cohorts.

Main Methods:

  • A retrospective study comparing STEMI patients treated with pPCI at tertiary centers in India and Australia from January 2017 to December 2019.
  • Data collected included patient demographics, procedural characteristics, times to reperfusion, and mortality.

Main Results:

  • Indian patients were younger, more likely male, and had higher rates of diabetes and lower BMI compared to Australian patients.
  • Indian patients experienced significantly longer symptom-to-balloon times but shorter door-to-balloon times.
  • Achieved TIMI III flow post-PCI was lower in Indian patients, but 30-day and 1-year mortality rates were not significantly different.

Conclusions:

  • Significant demographic and presentation differences exist between Indian and Australian STEMI patients undergoing pPCI.
  • Indian patients face longer pre-hospital delays and lower post-PCI flow, despite shorter in-hospital treatment times, with comparable mortality outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
419
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
763
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
473